| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CMET.2011.12.011 |
| P698 | PubMed publication ID | 22225869 |
| P50 | author | Ubaldo E Martinez-Outschoorn | Q37828916 |
| P2093 | author name string | Federica Sotgia | |
| Michael P Lisanti | |||
| P433 | issue | 1 | |
| P304 | page(s) | 4-5 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Cell Metabolism | Q1254684 |
| P1476 | title | Power surge: supporting cells "fuel" cancer cell mitochondria | |
| P478 | volume | 15 |
| Q26826123 | Adipose tissue and adipocytes support tumorigenesis and metastasis |
| Q40863052 | Adipose tissue and muscle attenuation as novel biomarkers predicting mortality in patients with extremity sarcomas. |
| Q36059690 | Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production |
| Q35475688 | Biological insights through nontargeted metabolomics. |
| Q39428665 | Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation |
| Q39062508 | Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms |
| Q58734172 | Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF) |
| Q36338756 | CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis |
| Q36906195 | Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer |
| Q38824435 | Cancer metabolism: a therapeutic perspective |
| Q42962693 | Cancer metabolism: new validated targets for drug discovery |
| Q42096679 | Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs |
| Q36724291 | Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. |
| Q45067426 | Classifying the evolutionary and ecological features of neoplasms |
| Q36906190 | Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis |
| Q49164235 | Contribution of Adipose Tissue to Development of Cancer. |
| Q36654392 | Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo. |
| Q38741833 | Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance |
| Q37747513 | Emerging roles of lipid metabolism in cancer metastasis |
| Q28708831 | Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention |
| Q43083276 | Genetic induction of the Warburg effect inhibits tumor growth |
| Q46238305 | Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. |
| Q38875398 | Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration |
| Q89341680 | Interaction with adipocytes induces lung adenocarcinoma A549 cell migration and tumor growth |
| Q26991931 | Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming |
| Q36426491 | Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells |
| Q34307146 | Ketone body utilization drives tumor growth and metastasis |
| Q33888770 | Lipid degradation promotes prostate cancer cell survival |
| Q37733747 | MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer |
| Q55283808 | Measuring the lactate-to-creatine ratio via 1H NMR spectroscopy can be used to noninvasively evaluate apoptosis in glioma cells after X-ray irradiation. |
| Q47335770 | Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer |
| Q36304167 | Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth |
| Q36235529 | Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production. |
| Q48254107 | Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial |
| Q36556326 | Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells |
| Q38036915 | Mitochondria in relation to cancer metastasis. |
| Q36328030 | Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. |
| Q91834908 | Mitochondrial and Lipid Droplet Dynamics Regulate Intra- and Intercellular Fatty Acid Trafficking |
| Q33978623 | Mitochondrial and cellular mechanisms for managing lipid excess |
| Q36472242 | Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance |
| Q38862527 | Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells |
| Q36604623 | Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin. |
| Q36339227 | Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth |
| Q35954906 | Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue |
| Q41652439 | Multicompartment metabolism in papillary thyroid cancer |
| Q42431355 | New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells |
| Q28076686 | Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression |
| Q37396904 | Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. |
| Q26851813 | Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery |
| Q47285774 | Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer |
| Q41591994 | Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5. |
| Q26771312 | Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis |
| Q37516025 | Redox-optimized ROS balance and the relationship between mitochondrial respiration and ROS. |
| Q37628179 | Stromal Modulators of TGF-β in Cancer |
| Q49727332 | TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer |
| Q60628574 | Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts |
| Q52594771 | The Influence of Breast Tumour-Derived Factors and Wnt Antagonism on the Transformation of Adipose-Derived Mesenchymal Stem Cells into Tumour-Associated Fibroblasts. |
| Q37031290 | The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis |
| Q36920538 | Thyroid Cancer Metabolism: A Review |
| Q37106988 | Triggering the landslide: The tumor-promotional effects of myofibroblasts |
| Q35835213 | Tumor microenvironment promotes dicarboxylic acid carrier-mediated transport of succinate to fuel prostate cancer mitochondria |
| Q36116239 | Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells |
| Q35911155 | Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers |
| Q41911837 | Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). |
Search more.